Ginkgo Bioworks Holdings (DNA) Operating Leases (2022 - 2026)

Ginkgo Bioworks Holdings (DNA) has 5 years of Operating Leases data on file, last reported at $410.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 5.49% year-over-year to $410.7 million; the trailing twelve-month figure through Mar 2026 stood at $410.7 million (down 5.49% YoY), and the FY2025 full-year result was $417.1 million, down 4.94% from the prior year.
• Operating Leases for Q1 2026 stood at $410.7 million, down from $417.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $452.3 million in Q2 2024 and bottomed at $221.8 million in Q4 2023.
• The 5-year median for Operating Leases is $415.2 million (2022), against an average of $395.6 million.
• The widest annual swing landed in 2023, when Operating Leases sank 46.32%; it then jumped 97.79% in 2024.
• A 5-year view of Operating Leases shows it stood at $413.3 million in 2022, then slumped by 46.32% to $221.8 million in 2023, then jumped by 97.79% to $438.8 million in 2024, then fell by 4.94% to $417.1 million in 2025, then fell by 1.53% to $410.7 million in 2026.
• The last three Operating Leases figures came in at $410.7 million (Q1 2026), $417.1 million (Q4 2025), and $422.9 million (Q3 2025), per Business Quant data.

Peer Comparison